about
Toxic myopathiesA randomized controlled trial of methotrexate for patients with generalized myasthenia gravisPhase II trial of methotrexate in myasthenia gravis.Diabetic neuropathy part 1: overview and symmetric phenotypesCryptogenic sensory polyneuropathy.Pompe disease: literature review and case seriesDisease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathyThe effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy.Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy.Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial.A genome-wide association study of myasthenia gravisA Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centers.Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.Diabetic neuropathy part 2: proximal and asymmetric phenotypes.Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy.Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.Less is More in Diabetic Neuropathy Diagnosis: Comparison of Quantitative Sudomotor Axon Reflex and Skin Biopsy.Benefit of Qigong exercise in patients with fibromyalgia: a pilot study.Aerobic exercise improves measures of vascular health in diabetic peripheral neuropathy.Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.North America and South America (NA-SA) neuropathy project.MRI tissue characterization of experimental cerebral ischemia in rat.Multiparametric MRI ISODATA ischemic lesion analysis: correlation with the clinical neurological deficit and single-parameter MRI techniques.Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.Diagnosis of Myasthenia Gravis.Tissue characterization in cerebral ischemia using multiparameter MRI
P50
Q27007256-B414A7AB-DE8A-4CB3-B38D-C8BA0F915229Q30276605-06C2944D-C877-46A2-8975-D082E6F291ABQ30415984-7BA58181-A8D1-4E51-B71B-90648ADEFC3AQ33878023-8B2D3081-F493-440E-82CC-6A046360A27CQ33878084-04BFC426-1878-47DC-B277-16A100ECFE32Q35029971-E8A7CF47-C589-42DE-BB7F-0C84E9485B04Q35900966-86694F53-7E2E-4C82-B4D9-D571B04BF89DQ36092349-0328B24C-C347-40E4-9C85-04C8B3AB3625Q36218520-308F6C80-409C-425B-AB6E-94FF45B3E42CQ36358287-D21B0335-8413-4A58-B3F6-4C948C793F56Q36590922-64045CA2-7BBB-4F81-9752-6E80DB1994C0Q36869250-E45306E5-48D2-4DBD-B732-E88999FAF946Q37220654-804CE3CA-43FB-4856-9016-94745C11C5E2Q37625980-344638A0-2FC6-460A-92EC-4E3B72442CB2Q37734743-0CC6C362-F8D2-45FD-BAC7-9FAD79530FA7Q37987776-E2BBFD00-2B64-4A9B-95E6-65CCC67AA0F7Q38104041-67ADC145-00DD-4725-8579-AA3AC712D722Q38264130-358A2C66-991F-4E57-9EC1-78133D3366EAQ38372339-4FD0EDAF-5715-4C5B-B6E2-167E0DAC137FQ38615405-EF6F9DF5-FDB5-4EE0-9313-B2ADEDD9EDB4Q39588048-D9896304-C5F2-449F-8FA7-CB5485344EC7Q40088362-E9D3039E-C843-41AC-B94F-6C4DF52FD84AQ41498775-1980615B-0057-4BEF-9A68-154A8DEBEDB9Q42272505-B2ADD94D-2A95-41B3-BFDE-5918DD3E4D99Q48355330-D81E9BEE-245F-473E-AB7A-2CD71A8A01A6Q48431385-6BE2C57F-BFCC-41A4-982C-8DAF0BF68FFDQ54116089-230F3FB0-40B8-4992-ACBF-F14345C5F740Q54116095-3F7389F5-157A-436D-95C3-7286C302C71BQ62839714-86C4A225-DA0A-4AC8-BE17-25A13B883942
P50
name
Mamatha Pasnoor
@ast
Mamatha Pasnoor
@en
Mamatha Pasnoor
@nl
type
label
Mamatha Pasnoor
@ast
Mamatha Pasnoor
@en
Mamatha Pasnoor
@nl
prefLabel
Mamatha Pasnoor
@ast
Mamatha Pasnoor
@en
Mamatha Pasnoor
@nl